References:

1. Baskota SU, Qazi, D., Chandra, A., & Vohra, P.: Comprehensive Review of Metastatic Breast Carcinoma in Cytology Specimens. Journal of Molecular Pathology 2022, 3(4):293-306.
2. Chen MT, Sun HF, Zhao Y, Fu WY, Yang LP, Gao SP, Li LD, Jiang HL, Jin W: Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep 2017, 7(1):9254.
3. Almasi S, Kuthi L, Sejben A, Voros A, Nagy A, Zombori T, Cserni G: TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin. Virchows Arch 2023, 482(5):861-868.
4. Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT et al: TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol 2022, 125:97-107.
5. Gown AM, Fulton RS, Kandalaft PL: Markers of metastatic carcinoma of breast origin. Histopathology 2016, 68(1):86-95.
6. Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J et al: GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 2014, 38(1):13-22.